Analysis of new colorectal cancer immunotherapy shows more treatment options
A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive immune checkpoint inhibitor treatments for colorectal cancer in the U.S.
Mar 20, 2025
0
26